Bayer announced Sue Ann Pentecost as the new Vice President, Head of Pharmaceuticals Communications in the United States. She will report directly to Beth Roden, Senior Vice President, Head of Communications for Bayer U.S., and Head of Communications Bayer Consumer Health NA. Pentecost succeeds Lori Moore, who is retiring at the end of May.

Pentecost joined Bayer in 2022 as Head, External Communications for U.S. Pharmaceuticals responsible for above brand efforts to support business priorities. Her role expanded to include U.S. Oncology communications, where she drove creative campaigns in the prostate cancer space. More recently, Pentecost has played an integral role on key corporate media relations initiatives to continue building Bayer?s reputation in the U.S. market.

In her new role, Pentecost will be responsible for developing and executing fully integrated programs to advance the reputation of Bayer overall with an emphasis on the U.S. Pharmaceuticals business and brands. Pentecost has more than 25 years? experience in executive, external and internal communications with a focus in health care.

Prior to joining Bayer, she spent 14 years at PPD Inc., now part of Thermo Fisher Scientific, where she held a variety of leadership roles across communications and marketing. Pentecost has a bachelor?s degree in journalism and mass communication from The University of North Carolina at Chapel Hill and a master?s degree in communication from North Carolina State University. She and her family will re-locate to the New Jersey area in the coming months.